Robert E. Waltermire - Net Worth and Insider Trading

Robert E. Waltermire Net Worth

The estimated net worth of Robert E. Waltermire is at least $2 Million dollars as of 2024-11-05. Robert E. Waltermire is the Senior VP, Chief Pharma Dev. of Madrigal Pharmaceuticals Inc and owns about 5,500 shares of Madrigal Pharmaceuticals Inc (MDGL) stock worth over $2 Million. Details can be seen in Robert E. Waltermire's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert E. Waltermire has not made any transactions after 2024-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Robert E. Waltermire

To

Robert E. Waltermire Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert E. Waltermire owns 1 companies in total, including Madrigal Pharmaceuticals Inc (MDGL) .

Click here to see the complete history of Robert E. Waltermire’s form 4 insider trades.

Insider Ownership Summary of Robert E. Waltermire

Ticker Comapny Transaction Date Type of Owner
MDGL Madrigal Pharmaceuticals Inc 2024-06-14 Senior VP & Chief Pharma Dev.

Robert E. Waltermire Latest Holdings Summary

Robert E. Waltermire currently owns a total of 1 stock. Robert E. Waltermire owns 5,500 shares of Madrigal Pharmaceuticals Inc (MDGL) as of June 14, 2024, with a value of $2 Million.

Latest Holdings of Robert E. Waltermire

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MDGL Madrigal Pharmaceuticals Inc 2024-06-14 5,500 332.86 1,830,730

Holding Weightings of Robert E. Waltermire


Robert E. Waltermire Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert E. Waltermire has made a total of 5 transactions in Madrigal Pharmaceuticals Inc (MDGL) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Madrigal Pharmaceuticals Inc is the sale of 1,900 shares on June 14, 2024, which brought Robert E. Waltermire around $532,000.

Insider Trading History of Robert E. Waltermire

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert E. Waltermire Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert E. Waltermire Ownership Network

Ownership Network List of Robert E. Waltermire

No Data

Ownership Network Relation of Robert E. Waltermire

Insider Network Chart

Robert E. Waltermire Owned Company Details

What does Madrigal Pharmaceuticals Inc do?

Who are the key executives at Madrigal Pharmaceuticals Inc?

Robert E. Waltermire is the Senior VP & Chief Pharma Dev. of Madrigal Pharmaceuticals Inc. Other key executives at Madrigal Pharmaceuticals Inc include director & President and CEO William John Sibold , director & 10 percent owner Fred B Craves , and director & Chief Executive Officer Paul A Friedman .

Madrigal Pharmaceuticals Inc (MDGL) Insider Trades Summary

Over the past 18 months, Robert E. Waltermire made 5 insider transaction in Madrigal Pharmaceuticals Inc (MDGL) with a net sale of 12,736. Other recent insider transactions involving Madrigal Pharmaceuticals Inc (MDGL) include a net purchase of 424,685 shares made by Baker Bros. Advisors Lp , a net sale of 100,000 shares made by Paul A Friedman , and a net sale of 76,564 shares made by Rebecca Taub .

In summary, during the past 3 months, insiders sold 6,363 shares of Madrigal Pharmaceuticals Inc (MDGL) in total and bought 0 shares, with a net sale of 6,363 shares. During the past 18 months, 303,930 shares of Madrigal Pharmaceuticals Inc (MDGL) were sold and 424,685 shares were bought by its insiders, resulting in a net purchase of 120,755 shares.

Madrigal Pharmaceuticals Inc (MDGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Madrigal Pharmaceuticals Inc Insider Transactions

No Available Data

Robert E. Waltermire Mailing Address

Above is the net worth, insider trading, and ownership report for Robert E. Waltermire. You might contact Robert E. Waltermire via mailing address: Four Tower Bridge, 200 Barr Harbor Drive, Suite 200, West Conshohocken Pa 19428.